Kirkland & Ellis advised Ares Acquisition Corporation II on the transaction, while Wilson Sonsini Goodrich & Rosati advised Kodiak Robotics, Inc. Ropes & Gray advised the...
Ares Acquisition Corporation II’s Business Combination with Kodiak
MSD Investment Corp.’s $500 Million Bond Offering
Kirkland & Ellis advised MSD Investment Corp. on the offering, and Ropes & Gray represented the initial purchasers. MSD Investment Corp. (NYSE: MSD) announced its $500...
AdvanCell’s Collaboration with Eli Lilly and Company
Sidley Austin represented AdvanCell in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies,...
TCW Group’s Partnership With Nippon Life Insurance Company
Kirkland & Ellis advised The TCW Group, Inc. on the transaction. The TCW Group, Inc., a leading global asset manager, announced a transaction with Nippon Life...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Bain Capital’s $250 Million Minority Investment in Sikich
Kirkland & Ellis and Hunton Andrews Kurth advised Bain Capital LP on the transaction, while Holland & Knight and Vedder Price advised Sikich LLC. Sikich LLC,...
Ares Management’s $1.08 Billion Acquisition of Landmark Partners
Ropes & Gray represented BrightSphere Investment Group, Inc. and Landmark Partners, LLC, while Kirkland & Elis LLP represented Ares on the deal. Ares Management Corporation (“Ares”)...